Interobserver variation in parotid gland delineation: a study of its impact on intensity-modulated radiotherapy solutions with a systematic review of the literature
- PMID: 22815411
- PMCID: PMC3587103
- DOI: 10.1259/bjr/32038456
Interobserver variation in parotid gland delineation: a study of its impact on intensity-modulated radiotherapy solutions with a systematic review of the literature
Abstract
Objectives: This study evaluates the interobserver variation in parotid gland delineation and its impact on intensity-modulated radiotherapy (IMRT) solutions.
Methods: The CT volumetric data sets of 10 patients with oropharyngeal squamous cell carcinoma who had been treated with parotid-sparing IMRT were used. Four radiation oncologists and three radiologists delineated the parotid gland that had been spared using IMRT. The dose-volume histogram (DVH) for each study contour was calculated using the IMRT plan actually delivered for that patient. This was compared with the original DVH obtained when the plan was used clinically.
Results: 70 study contours were analysed. The mean parotid dose achieved during the actual treatment was within 10% of 24 Gy for all cases. Using the study contours, the mean parotid dose obtained was within 10% of 24 Gy for only 53% of volumes by radiation oncologists and 55% of volumes by radiologists. The parotid DVHs of 46% of the study contours were sufficiently different from those used clinically, such that a different IMRT plan would have been produced.
Conclusion: Interobserver variation in parotid gland delineation is significant. Further studies are required to determine ways of improving the interobserver consistency in parotid gland definition.
Figures




Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Comparison of Doses to Parotid, Temporomandibular Joint, and Pharyngeal Constrictor Muscles Using Different Techniques in Radiotherapy for Oropharyngeal Cancer.Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241260646. doi: 10.1177/15330338241260646. Technol Cancer Res Treat. 2024. PMID: 38841792 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.Cochrane Database Syst Rev. 2016 Dec 11;12(12):CD010963. doi: 10.1002/14651858.CD010963.pub2. Cochrane Database Syst Rev. 2016. PMID: 27943254 Free PMC article.
-
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130. Health Technol Assess. 2007. PMID: 17408534
Cited by
-
Interobserver Variability in a Spanish Society of Radiation Oncology (SEOR) Head and Neck Course. Is Current Contouring Training Sufficient?Adv Radiat Oncol. 2024 Aug 10;9(11):101591. doi: 10.1016/j.adro.2024.101591. eCollection 2024 Nov. Adv Radiat Oncol. 2024. PMID: 39493292 Free PMC article.
-
Convolutional neural network-based automatic liver delineation on contrast-enhanced and non-contrast-enhanced CT images for radiotherapy planning.Rep Pract Oncol Radiother. 2020 Nov-Dec;25(6):981-986. doi: 10.1016/j.rpor.2020.09.005. Epub 2020 Oct 2. Rep Pract Oncol Radiother. 2020. PMID: 33100915 Free PMC article.
-
Evaluation of diffusion weighted imaging for tumor delineation in head-and-neck radiotherapy by comparison with automatically segmented 18F-fluorodeoxyglucose positron emission tomography.Phys Imaging Radiat Oncol. 2018 Jan 30;5:13-18. doi: 10.1016/j.phro.2017.12.004. eCollection 2018 Jan. Phys Imaging Radiat Oncol. 2018. PMID: 33458363 Free PMC article.
-
Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.Radiol Med. 2019 Jul;124(7):682-692. doi: 10.1007/s11547-019-01006-y. Epub 2019 Mar 9. Radiol Med. 2019. PMID: 30852793
-
A Systematic Review of Contouring Guidelines in Radiation Oncology: Analysis of Frequency, Methodology, and Delivery of Consensus Recommendations.Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):827-835. doi: 10.1016/j.ijrobp.2020.04.011. Epub 2020 Apr 18. Int J Radiat Oncol Biol Phys. 2020. PMID: 32311418 Free PMC article.
References
-
- Epstein JB, Emerton S, Kolbinson DA, Le ND, Phillips N, Stevenson-Moore P, et al. Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 1999;21:1–11 - PubMed
-
- Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer 2002;94:1131–41 - PubMed
-
- Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 2004;26:796–807 - PubMed
-
- McMillan AS, Pow EH, Leung WK, Wong MC, Kwong DL. Oral health-related quality of life in southern Chinese following radiotherapy for nasopharyngeal carcinoma. J Oral Rehabil 2004;31:600–8 - PubMed
-
- Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69:751–60 - PubMed